Back to search
CPSCCPSC · Consumer products·Recall number 26157

Mamisan Pain Relieving Topical Ointment

Published December 18, 2025 · Recall initiated: December 18, 2025

What's the hazard

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

What to do

Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.

Recall details

Brand
MiramarLab, of Doral, Florida
Manufacturer
MiramarLab, of Doral, Florida
Distributor
Plantimex Distributors, Inc., of San Diego, California
UPC
860006498115
Country
US
View official CPSC notice

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card